• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺许特莱细胞癌:临床、病理及分子特征

Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features.

作者信息

Kure Shoko, Ohashi Ryuji

机构信息

Integrated Diagnostic Pathology, Nippon Medical School, 1-1-5 Sendagi, Bunkyoku, Tokyo 113-8602, Japan.

出版信息

Cancers (Basel). 2020 Dec 23;13(1):26. doi: 10.3390/cancers13010026.

DOI:10.3390/cancers13010026
PMID:33374707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7793513/
Abstract

Hürthle cell carcinoma (HCC) represents 3-4% of thyroid carcinoma cases. It is considered to be more aggressive than non-oncocytic thyroid carcinomas. However, due to its rarity, the pathological characteristics and biological behavior of HCC remain to be elucidated. The Hürthle cell is characterized cytologically as a large cell with abundant eosinophilic, granular cytoplasm, and a large hyperchromatic nucleus with a prominent nucleolus. Cytoplasmic granularity is due to the presence of numerous mitochondria. These mitochondria display packed stacking cristae and are arranged in the center. HCC is more often observed in females in their 50-60s. Preoperative diagnosis is challenging, but indicators of malignancy are male, older age, tumor size > 4 cm, a solid nodule with an irregular border, or the presence of psammoma calcifications according to ultrasound. Thyroid lobectomy alone is sufficient treatment for small, unifocal, intrathyroidal carcinomas, or clinically detectable cervical nodal metastases, but total thyroidectomy is recommended for tumors larger than 4 cm. The effectiveness of radioactive iodine is still debated. Molecular changes involve cellular signaling pathways and mitochondria-related DNA. Current knowledge of Hürthle cell carcinoma, including clinical, pathological, and molecular features, with the aim of improving clinical management, is reviewed.

摘要

许特莱细胞癌(HCC)占甲状腺癌病例的3%-4%。它被认为比非嗜酸性甲状腺癌更具侵袭性。然而,由于其罕见性,HCC的病理特征和生物学行为仍有待阐明。许特莱细胞在细胞学上的特征是细胞大,胞质丰富、嗜酸性、呈颗粒状,核大、深染,核仁突出。胞质颗粒状是由于存在大量线粒体。这些线粒体显示出紧密堆积的嵴并排列在中央。HCC在50-60多岁的女性中更常见。术前诊断具有挑战性,但根据超声检查,恶性肿瘤的指标包括男性、年龄较大、肿瘤大小>4cm、边界不规则的实性结节或存在砂粒体钙化。对于小的、单灶性、甲状腺内癌或临床上可检测到的颈部淋巴结转移,单纯甲状腺叶切除术是足够的治疗方法,但对于大于4cm的肿瘤,建议行全甲状腺切除术。放射性碘的有效性仍存在争议。分子变化涉及细胞信号通路和线粒体相关DNA。本文综述了目前关于许特莱细胞癌的知识,包括临床、病理和分子特征,旨在改善临床管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b094/7793513/e3c5301be66d/cancers-13-00026-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b094/7793513/c0f58173ac46/cancers-13-00026-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b094/7793513/f0096d16db57/cancers-13-00026-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b094/7793513/53a10a9e237a/cancers-13-00026-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b094/7793513/e3c5301be66d/cancers-13-00026-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b094/7793513/c0f58173ac46/cancers-13-00026-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b094/7793513/f0096d16db57/cancers-13-00026-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b094/7793513/53a10a9e237a/cancers-13-00026-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b094/7793513/e3c5301be66d/cancers-13-00026-g004.jpg

相似文献

1
Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features.甲状腺许特莱细胞癌:临床、病理及分子特征
Cancers (Basel). 2020 Dec 23;13(1):26. doi: 10.3390/cancers13010026.
2
Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.甲状腺嗜酸性细胞肿瘤患者的预后因素
Cancer. 2003 Mar 1;97(5):1186-94. doi: 10.1002/cncr.11176.
3
Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.低分化嗜酸性(许特莱细胞)滤泡癌:一项机构经验。
Endocr Pathol. 2015 May;26(2):164-9. doi: 10.1007/s12022-015-9367-6.
4
Unraveling the Enigma: A Five-Year Comprehensive Analysis of Hurthle Cell Tumors in South India's Tertiary Care Center.解开谜团:对印度南部三级护理中心甲状腺嗜酸细胞肿瘤的五年综合分析
Cureus. 2024 Mar 29;16(3):e57166. doi: 10.7759/cureus.57166. eCollection 2024 Mar.
5
Fine needle aspiration of poorly differentiated oxyphilic (Hürthle cell) thyroid carcinoma: a case report.细针穿刺诊断低分化嗜酸性(许特莱细胞)甲状腺癌:病例报告
Acta Cytol. 2006 Sep-Oct;50(5):560-2. doi: 10.1159/000326016.
6
Hürthle cell carcinoma: current perspectives.许特莱细胞癌:当前观点
Onco Targets Ther. 2016 Nov 7;9:6873-6884. doi: 10.2147/OTT.S119980. eCollection 2016.
7
Hurthle cell tumor.许特耳细胞肿瘤
Int Surg. 1996 Apr-Jun;81(2):168-70.
8
Hürthle cell carcinoma: a clinicopathological study of thirteen cases.许特莱细胞癌:13例临床病理研究
Nucl Med Commun. 2006 Apr;27(4):377-9. doi: 10.1097/01.mnm.0000202862.74917.0c.
9
Unilateral lobectomy for Hurthle cell adenoma.嗜酸性细胞腺瘤的单侧肺叶切除术。
Am Surg. 1998 Aug;64(8):729-32; discussion 732-3.
10
Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy?甲状腺许特耳细胞肿瘤:是否存在预测恶性肿瘤的因素?
Ann Surg. 1998 Apr;227(4):542-6. doi: 10.1097/00000658-199804000-00015.

引用本文的文献

1
Ultrasound Pattern of Indeterminate Thyroid Nodules with Prevalence of Oncocytes.具有嗜酸性细胞为主的甲状腺结节的超声特征
J Clin Med. 2025 Jul 23;14(15):5206. doi: 10.3390/jcm14155206.
2
Differentiating oncocytic carcinoma from oncocytic adenoma: a comprehensive evaluation of preoperative characteristics and diagnostic approaches in a retrospective cohort study.鉴别嗜酸细胞癌与嗜酸细胞腺瘤:一项回顾性队列研究中术前特征及诊断方法的综合评估
Ann Surg Treat Res. 2025 Aug;109(2):105-112. doi: 10.4174/astr.2025.109.2.105. Epub 2025 Jul 30.
3
Integrated analysis of microbiome and host transcriptome revealed correlations between tissue microbiota and tumor progression in early-stage papillary thyroid carcinoma.

本文引用的文献

1
Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer.致病性异质性体细胞线粒体DNA突变赋予高级别浆液性卵巢癌铂耐药性及复发能力。
Cancer Manag Res. 2020 Nov 2;12:11085-11093. doi: 10.2147/CMAR.S277724. eCollection 2020.
2
Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers.线粒体突变与线粒体表观遗传学:聚焦于调控乳腺癌中氧化应激诱导反应。
Semin Cancer Biol. 2022 Aug;83:556-569. doi: 10.1016/j.semcancer.2020.09.012. Epub 2020 Oct 6.
3
Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study.
微生物组与宿主转录组的综合分析揭示了早期乳头状甲状腺癌组织微生物群与肿瘤进展之间的相关性。
Front Cell Infect Microbiol. 2025 Jun 9;15:1571341. doi: 10.3389/fcimb.2025.1571341. eCollection 2025.
4
A Case of Tumor-to-Tumor Metastasis: Breast Carcinoma Metastatic to Oncocytic Carcinoma of Thyroid.肿瘤-to-肿瘤转移病例:乳腺癌转移至甲状腺嗜酸细胞癌
Kans J Med. 2025 Apr 14;18(2):46-48. doi: 10.17161/kjm.vol18.23026. eCollection 2025 Mar-Apr.
5
To establish and validate autophagy related biomarkers for the diagnosis of IgA nephropathy.建立并验证用于诊断IgA肾病的自噬相关生物标志物。
Sci Rep. 2025 Apr 22;15(1):13944. doi: 10.1038/s41598-025-98591-y.
6
Outcome analysis of differentiated thyroid cancer: Experience from tertiary care in Karachi.分化型甲状腺癌的结局分析:来自卡拉奇三级医疗中心的经验
Pak J Med Sci. 2024 Dec;40(11):2631-2635. doi: 10.12669/pjms.40.11.7036.
7
Liquid biopsy in cancer current: status, challenges and future prospects.癌症液体活检的现状、挑战与未来前景
Signal Transduct Target Ther. 2024 Dec 2;9(1):336. doi: 10.1038/s41392-024-02021-w.
8
Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Papillary Thyroid Carcinoma Variants.基于机器学习算法的甲状腺乳头状癌变异型预后模型与治疗结局。
Cancer Rep (Hoboken). 2024 Dec;7(12):e70071. doi: 10.1002/cnr2.70071.
9
Molecular Markers in Follicular and Oncocytic Thyroid Carcinomas: Clinical Application of Molecular Genetic Testing.滤泡性和嗜酸细胞性甲状腺癌的分子标志物:分子遗传学检测的临床应用。
Curr Oncol. 2024 Oct 1;31(10):5919-5928. doi: 10.3390/curroncol31100441.
10
Comparison of prognosis between oncocytic thyroid carcinoma and follicular thyroid carcinoma: a population-based propensity score matching analysis.嗜酸细胞性甲状腺癌与滤泡状甲状腺癌预后的比较:基于人群的倾向评分匹配分析
Eur Arch Otorhinolaryngol. 2025 Feb;282(2):993-1003. doi: 10.1007/s00405-024-08965-7. Epub 2024 Sep 11.
基于人群的研究:甲状腺滤泡细胞癌的临床特征和预后因素。
BMC Cancer. 2020 May 12;20(1):407. doi: 10.1186/s12885-020-06915-0.
4
The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.在甲状腺细针抽吸物的大多数 Bethesda 类别中,Hurthle 细胞的存在并不会增加恶性肿瘤的风险。
Thyroid. 2020 Mar;30(3):425-431. doi: 10.1089/thy.2019.0190.
5
The role of molecular testing in the diagnosis of medullary thyroid cancer: A case report of oncocytic medullary thyroid carcinoma and review of the literature.分子检测在甲状腺髓样癌诊断中的作用:一例嗜酸细胞性甲状腺髓样癌病例报告及文献复习。
Am J Otolaryngol. 2020 Jan-Feb;41(1):102312. doi: 10.1016/j.amjoto.2019.102312. Epub 2019 Nov 11.
6
Tumor mutational burden.肿瘤突变负荷
Cancer Cytopathol. 2019 Dec;127(12):735-736. doi: 10.1002/cncy.22174. Epub 2019 Aug 21.
7
mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.mRNA 表达作为甲状腺乳头状癌的一种新型预后标志物。
Thyroid. 2019 Aug;29(8):1105-1114. doi: 10.1089/thy.2018.0695. Epub 2019 Aug 5.
8
Diagnostic performance of thyroid ultrasound in Hürthle cell carcinomas.甲状腺超声对许特莱细胞癌的诊断效能
Arch Endocrinol Metab. 2019 May-Jun;63(3):300-305. doi: 10.20945/2359-3997000000131. Epub 2019 Apr 25.
9
Short Review: Genomic Alterations in Hürthle Cell Carcinoma.综述:甲状腺滤泡癌的基因组改变。
Thyroid. 2019 Apr;29(4):471-479. doi: 10.1089/thy.2019.0088.
10
Approach the Invasive Potential with Hurthle Cell Tumors of Thyroid.探讨甲状腺嗜酸性细胞肿瘤的侵袭潜能。
Pathol Oncol Res. 2019 Apr;25(2):697-701. doi: 10.1007/s12253-018-0546-x. Epub 2018 Dec 11.